GOSS · Gossamer Bio, Inc. · Off Exchange
$11.50
+0.07 (+0.61%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company has concluded that these circumstances and the uncertainties associated with the Company’s ability to obtain additional equity or debt financing on terms that are favorable to the Company, or at all, and otherwise succeed in its future operations raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
Market Cap
$68.69M
Shares
6.12M
Volume · Nov 19
143.82K
Avg daily vol (50 sessions)
251.05K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-10-12 | 287,409 | 302,712 | 590,121 | 43.2% |
| 2026-10-05 | 380,444 | 260,136 | 640,580 | 47.2% |
| 2026-09-28 | 498,385 | 314,248 | 812,633 | 43.4% |
| 2026-09-21 | 291,571 | 509,481 | 801,052 | 50.9% |
| 2026-09-14 | 182,750 | 403,558 | 586,308 | 36.3% |
| 2026-09-07 | 63,722 | 286,927 | 350,649 | 73.2% |
| 2026-08-31 | 48,414 | 256,770 | 305,184 | 100.0% |
| 2026-08-24 | 114,446 | 1,217,142 | 1,331,588 | 100.0% |
| 2026-08-17 | 76,322 | 1,353,895 | 1,430,217 | 100.0% |
| 2026-08-10 | 55,791 | 437,375 | 493,166 | 100.0% |
| 2026-08-03 | 71,914 | 424,065 | 495,979 | 100.0% |
| 2026-07-27 | 519,474 | 5,147,595 | 5,667,069 | 100.0% |
| 2026-07-20 | 190,306 | 732,912 | 923,218 | 100.0% |
| 2026-07-13 | 190,519 | 752,078 | 942,597 | 100.0% |
| 2026-07-06 | 131,214 | 434,691 | 565,905 | 100.0% |
| 2026-06-29 | 106,275 | 340,459 | 446,734 | 100.0% |
| 2026-06-22 | 111,276 | 451,746 | 563,022 | 100.0% |
| 2026-06-15 | 97,349 | 479,403 | 576,752 | 100.0% |
| 2026-06-08 | 147,979 | 698,795 | 846,774 | 100.0% |
| 2026-06-01 | 125,314 | 446,344 | 571,658 | 100.0% |
| 2026-05-25 | 128,284 | 351,250 | 479,534 | 100.0% |
| 2026-05-18 | 200,971 | 1,065,944 | 1,266,915 | 100.0% |
| 2026-05-11 | 28,956 | 88,578 | 117,534 | 100.0% |
| 2026-05-04 | 28,929 | 126,993 | 155,922 | 100.0% |
| 2026-04-27 | 50,534 | 140,310 | 190,844 | 100.0% |
| 2026-04-20 | 58,017 | 148,624 | 206,641 | 100.0% |
| 2026-04-13 | 74,331 | 174,493 | 248,824 | 100.0% |
| 2026-04-06 | 76,379 | 271,194 | 347,573 | 100.0% |
| 2026-03-30 | 61,269 | 193,858 | 255,127 | 100.0% |
| 2026-03-23 | 119,934 | 682,234 | 802,168 | 100.0% |
| 2026-03-16 | 121,878 | 356,496 | 478,374 | 100.0% |
| 2026-03-09 | 81,774 | 266,804 | 348,578 | 100.0% |
| 2026-03-02 | 120,098 | 685,808 | 805,906 | 100.0% |
| 2026-02-23 | 526,252 | 3,721,976 | 4,248,228 | 100.0% |
| 2026-02-16 | 58,690 | 96,501 | 155,191 | 100.0% |
| 2026-02-09 | 77,503 | 80,899 | 158,402 | 100.0% |
| 2026-02-02 | 115,718 | 103,767 | 219,485 | 100.0% |
| 2026-01-26 | 48,808 | 76,875 | 125,683 | 100.0% |
| 2026-01-19 | 51,938 | 82,771 | 134,709 | 100.0% |
| 2026-01-12 | 56,184 | 58,856 | 115,040 | 100.0% |
| 2026-01-05 | 70,683 | 106,545 | 177,228 | 100.0% |
| 2025-12-29 | 37,584 | 44,935 | 82,519 | 100.0% |
| 2025-12-22 | 43,101 | 66,343 | 109,444 | 100.0% |
| 2025-12-15 | 76,413 | 83,753 | 160,166 | 100.0% |
| 2025-12-08 | 36,810 | 46,822 | 83,632 | 100.0% |
| 2025-12-01 | 38,975 | 55,354 | 94,329 | 100.0% |
| 2025-11-24 | 13,160 | 26,199 | 39,359 | 100.0% |
Showing 1–47 of 47 weeks
Key facts
CIK
1728117
CUSIP
38341P201
13F (30d)
100 filings
75 filers
Visit website
Investor relations